SCNI

#5247
Scinai Immunotherapeutics Ltd - American Depositary Shares
0.0 0 USD
+2.27%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
0.00
0.00
년간 변동
0.00
1.05
일일 변동
+2.27%
월간 변동
-99.36%
6달 변화
-99.40%
년간 변동율
-99.40%
이전 종가
0.0 0
Open
0.0 0
저가
0.0 0
High
0.0 0
양
3
전체 차트 열기 Full chart

Financials

개요 성명 통계
4분기 연간
  • Market Capitalization 15.61 K
  • Employee 45
  • Founded 2003
  • CEO N/A
  • Website www.scinai.com
  • Headquarter Israel
  • FIGI BBG007TGL1R2
  • Industry 생명공학
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
791.22
주가매출액비율
5 072.94

Scinai Immunotherapeutics Ltd - American Depositary Shares

BiondVax Pharmaceuticals Ltd. is an Israeli biopharmaceutical company focused on developing and manufacturing immunotherapeutic products, primarily for the treatment of infectious diseases and autoimmune diseases. In collaboration with the Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Göttingen, both in Germany, BiondVax develops nanosized antibody therapies for diseases such as COVID-19, asthma and psoriasis.

뉴스